If you're currently experiencing moderate to severe symptoms associated with menopause, have just been prescribed CombiPatch®, or are already taking CombiPatch, you probably have questions. Below you'll find answers to many common questions about CombiPatch and hormone therapy.
Remember, the best way to get information about treatment is by talking to your doctor. Together, you both can make treatment decisions that are right for you.
CombiPatch is made specifically for women who still have their uterus. If you've had your uterus removed, ask your doctor about Vivelle-Dot® (estradiol transdermal system), an estrogen-only Delivery Optimized Thermodynamics (DOT) Matrix® technology patch. For important safety information, including Boxed Warning, about Vivelle-Dot, click here.
CombiPatch should not be used if you:
Talk to your doctor about what treatment option may be right for you.
DOT Matrix® is a registered trademark of Noven Pharmaceuticals, Inc.
You are now leaving the CombiPatch Web site and moving to an external Web site independently operated and not managed by Novogyne Pharmaceuticals. Novogyne assumes no responsibility for the content of the site.
You are now leaving the CombiPatch Web site and moving to an external Web site operated by Noven Pharmaceuticals, Inc., a partner with Novartis Pharmaceuticals Corporation in the joint venture Novogyne Pharmaceuticals.
You are now leaving the CombiPatch Web site and moving to an external Web site operated by Novartis Pharmaceuticals Corporation, a partner with Noven Pharmaceuticals, Inc. in the joint venture Novogyne Pharmaceuticals.